Clinical Trial

A Study of SHR-9803 for Injection in Patients With Advanced Solid Tumors

Name: A Study of SHR-9803 for Injection in Patients With Advanced Solid Tumors — clinical trial record (NCT06906731)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

This is an open label, multi-center, multiple doses Phase I/II study to evaluate the safety, tolerability ,pharmacokinetics and efficacy of SHR-9803 for injection in subjects with advanced solid tumors.

Trial Details

NCT Number	NCT06906731
Lead Sponsor	Jiangsu HengRui Medicine Co., Ltd.
Conditions	Advanced Solid Tumors
Enrollment	27 participants
Start Date	2025-04
Primary Completion	2027-06 (estimated)
Study Completion	2027-12 (estimated)
Updated on ClinicalTrials.gov	2025-04-02